{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:18:08Z","timestamp":1780755488744,"version":"3.54.1"},"reference-count":56,"publisher":"Japanese Society of Veterinary Science","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1292\/jvms.21-0671","type":"journal-article","created":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T22:09:16Z","timestamp":1656886156000},"page":"1134-1141","source":"Crossref","is-referenced-by-count":8,"title":["Protective effects of corni fructus extract in mice with potassium oxonate\u2013induced hyperuricemia"],"prefix":"10.1292","volume":"84","author":[{"given":"Chih-Chiang","family":"WANG","sequence":"first","affiliation":[{"name":"Department of Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Liang","family":"LI","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Master Program, Tajen University, Pingtung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yen","family":"CHIU","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Master Program, Tajen University, Pingtung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"CHEN","sequence":"additional","affiliation":[{"name":"School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Che","family":"CHEN","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Master Program, Tajen University, Pingtung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-An","family":"CHEN","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Master Program, Tajen University, Pingtung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Balakirski, G, Merk, HF. 2017. Cutaneous allergic drug reactions: update on pathophysiology, diagnostic procedures and differential diagnosic. Cutan Ocul Toxicol<\/i> 36: 307\u2013316.","DOI":"10.1080\/15569527.2017.1319379"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Becker, MA, Schumacher, HR Jr, Wortmann, RL, MacDonald, PA, Eustace, D, Palo, WA, Streit, J, Joseph-Ridge, N. 2005. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med<\/i> 353: 2450\u20132461.","DOI":"10.1056\/NEJMoa050373"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chen, Y, Li, C, Duan, S, Yuan, X, Liang, J, Hou, S. 2019. Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice. Biomed Pharmacother<\/i> 118: 109195.","DOI":"10.1016\/j.biopha.2019.109195"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Collins, MW, Saag, KG and Singh, JA. 2019. Is there a role for cherries in the management of gout? Ther Adv Musculoskelet Dis<\/i> 11:1759720X19847018.","DOI":"10.1177\/1759720X19847018"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dong, Y, Feng, ZL, Chen, HB, Wang, FS, Lu, JH. 2018. Corni Fructus<\/i>: a review of chemical constituents and pharmacological activities. Chin Med<\/i> 13: 34.","DOI":"10.1186\/s13020-018-0191-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Engel, B, Just, J, Bleckwenn, M, Weckbecker, K. 2017. Treatment options for gout. Dtsch Arztebl Int<\/i> 114: 215\u2013222.","DOI":"10.3238\/arztebl.2017.0215"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gay, GR. 1990. Another side effect of NSAIDs. JAMA<\/i> 264: 2677\u20132678.","DOI":"10.1001\/jama.264.20.2677"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Grosser, T, Ricciotti, E, FitzGerald, GA. 2017. The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci<\/i> 38: 733\u2013748.","DOI":"10.1016\/j.tips.2017.05.008"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hammer, B, Link, A, Wagner, A, B\u00f6hm, M. 2001. Hypersensitivity syndrome during therapy with allopurinol in asymptomatic hyperuricemia with a fatal outcome. Dtsch Med Wochenschr<\/i> 126: 1331\u20131334 (in German).","DOI":"10.1055\/s-2001-18563"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Harirforoosh, S, Asghar, W, Jamali, F. 2013. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci<\/i> 16: 821\u2013847.","DOI":"10.18433\/J3VW2F"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Harr, T, French, LE. 2010. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis<\/i> 5: 39.","DOI":"10.1186\/1750-1172-5-39"},{"key":"12","unstructured":"12. Hu, QH, Zhang, X, Wang, Y, Kong, LD. 2010. Mangiferin promotes uric acid excretion and kidney function improvement and modulates related renal transporters in hyperuricemic mice. Yao Xue Xue Bao<\/i> 45: 1239\u20131246 (in Chinese)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Huang, J, Wang, S, Zhu, M, Chen, J, Zhu, X. 2011. Effects of genistein, apigenin, quercetin, rutin and astilbin on serum uric acid levels and xanthine oxidase activities in normal and hyperuricemic mice. Food Chem Toxicol<\/i> 49: 1943\u20131947.","DOI":"10.1016\/j.fct.2011.04.029"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Huang, J, Zhang, Y, Dong, L, Gao, Q, Yin, L, Quan, H, Chen, R, Fu, X, Lin, D. 2018. Ethnopharmacology, phytochemistry, and pharmacology of Cornus officinalis Sieb. et Zucc. J Ethnopharmacol<\/i> 213: 280\u2013301.","DOI":"10.1016\/j.jep.2017.11.010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Jordan, A, Gresser, U. 2018. Side effects and interactions of the xanthine oxidase inhibitor febuxostat. Pharmaceuticals (Basel)<\/i> 11: 11.","DOI":"10.3390\/ph11020051"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kamel, B, Graham, GG, Williams, KM, Pile, KD, Day, RO. 2017. Clinical pharmacokinetics and pharmacodynamics of febuxostat. Clin Pharmacokinet<\/i> 56: 459\u2013475.","DOI":"10.1007\/s40262-016-0466-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kaufmann, P, T\u00f6r\u00f6k, M, H\u00e4nni, A, Roberts, P, Gasser, R, Kr\u00e4henb\u00fchl, S. 2005. Mechanisms of benzarone and benzbromarone-induced hepatic toxicity. Hepatology<\/i> 41: 925\u2013935.","DOI":"10.1002\/hep.20634"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Khanna, D, Fitzgerald, JD, Khanna, PP, Bae, S, Singh, MK, Neogi, T, Pillinger, MH, Merill, J, Lee, S, Prakash, S, Kaldas, M, Gogia, M, Perez-Ruiz, F, Taylor, W, Liot\u00e9, F, Choi, H, Singh, JA, Dalbeth, N, Kaplan, S, Niyyar, V, Jones, D, Yarows, SA, Roessler, B, Kerr, G, King, C, Levy, G, Furst, DE, Edwards, NL, Mandell, B, Schumacher, HR, Robbins, M, Wenger, N, Terkeltaub, R. American College of Rheumatology. 2012. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken)<\/i> 64: 1431\u20131446.","DOI":"10.1002\/acr.21772"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kuo, CF, Grainge, MJ, See, LC, Yu, KH, Luo, SF, Zhang, W, Doherty, M. 2015. Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Res Ther<\/i> 17: 13\u201313.","DOI":"10.1186\/s13075-015-0522-8"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kuo, CF, Grainge, MJ, Mallen, C, Zhang, W, Doherty, M. 2015. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis<\/i> 74: 661\u2013667.","DOI":"10.1136\/annrheumdis-2013-204463"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lee, CF, Fan, CW, Chiang, NN, Chang, HC, Chen, C, Huang, YS, Wang, HY, Lin, WC, Chen, FA. 2019. Protective effect of Corchorus capsularis L. leaves on ethanol-induced acute gastric mucosal lesion in rats. J Vet Med Sci<\/i> 81: 1636\u20131642.","DOI":"10.1292\/jvms.19-0054"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lerch, M, Mainetti, C, Terziroli Beretta-Piccoli, B, Harr, T. 2018. Current perspectives on erythema multiforme. Clin Rev Allergy Immunol<\/i> 54: 177\u2013184.","DOI":"10.1007\/s12016-017-8667-7"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lin, CM, Chen, CS, Chen, CT, Liang, YC, Lin, JK. 2002. Molecular modeling of flavonoids that inhibits xanthine oxidase. Biochem Biophys Res Commun<\/i> 294: 167\u2013172.","DOI":"10.1016\/S0006-291X(02)00442-4"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lin, JK, Tsai, SH, Lin-Shiau, SY. 2001. Antiinflammatory and antitumor effects of flavonoids and flavanoids. Drugs Future<\/i> 26: 145\u2013152.","DOI":"10.1358\/dof.2001.026.02.858703"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Link, EM, Riley, PA. 1988. Role of hydrogen peroxide in the cytotoxicity of the xanthine\/xanthine oxidase system. Biochem J<\/i> 249: 391\u2013399.","DOI":"10.1042\/bj2490391"},{"key":"26","unstructured":"26. Marini, R. P. 2009. Growing Cherries in Virginia, Virginia Cooperative Extension, 422-018, VCE Publications, Blacksburg."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Marsico, F., Paolillo, S. and Filardi, P. P. 2017. NSAIDs and cardiovascular risk. J. Cardiovasc. Med. (Hagerstown)<\/i> 18 Suppl 1: Special Issue on The State of the Art for the Practicing Cardiologist: The 2016 Conoscere E Curare Il Cuore (CCC) Proceedings from the CLI Foundation: e40-e43.","DOI":"10.2459\/JCM.0000000000000443"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Martinon, F. 2010. Update on biology: uric acid and the activation of immune and inflammatory cells. Curr Rheumatol Rep<\/i> 12: 135\u2013141.","DOI":"10.1007\/s11926-010-0092-3"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Moriwaki, Y, Okuda, C, Yamamoto, A, Ka, T, Tsutsumi, Z, Takahashi, S, Yamamoto, T, Kitadate, K, Wakame, K. 2011. Effects of Oligonol\u00ae, an oligomerized polyphenol formulated from lychee fruit, on serum concentration and urinary excretion of uric acid. J Funct Foods<\/i> 3: 13\u201316.","DOI":"10.1016\/j.jff.2010.11.002"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Murrell, GA, Rapeport, WG. 1986. Clinical pharmacokinetics of allopurinol. Clin Pharmacokinet<\/i> 11: 343\u2013353.","DOI":"10.2165\/00003088-198611050-00001"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Murugan, DD, Md Zain, Z, Choy, KW, Zamakshshari, NH, Choong, MJ, Lim, YM, Mustafa, MR. 2020. Edible bird\u2019s nest protects against hyperglycemia-induced oxidative stress and endothelial dysfunction. Front Pharmacol<\/i> 10: 1624.","DOI":"10.3389\/fphar.2019.01624"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Nile, SH, Ko, EY, Kim, DH, Keum, YS. 2016. Screening of ferulic acid related compounds as inhibitors of xanthine oxidase and cyclooxygenase-2 with anti-inflammatory activity. Rev Bras Farmacogn<\/i> 26: 50\u201355.","DOI":"10.1016\/j.bjp.2015.08.013"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Omar, B, Mohamed, N, Rahim, RA, Wahab, HA. 2007. Natural flavonoids for the treatment of hyperuricemia, molecular docking studies. pp. 178\u2013182. In: World Congress on Medical Physics and Biomedical Engineering 2006 (Magjarevic R and Nagel JH eds.), Springer Berlin Heidelberg, Berlin, Heidelberg.","DOI":"10.1007\/978-3-540-36841-0_53"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Pacher, P, Nivorozhkin, A, Szab\u00f3, C. 2006. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev<\/i> 58: 87\u2013114.","DOI":"10.1124\/pr.58.1.6"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Park, CH, Tanaka, T, Kim, HY, Park, JC, Yokozawa, T. 2012. Protective effects of corni fructus against advanced glycation endproducts and radical scavenging. Evid Based Complement Alternat Med<\/i> 2012: 418953.","DOI":"10.1155\/2012\/418953"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Park, CH, Noh, JS, Tanaka, T, Uebaba, K, Cho, EJ, Yokozawa, T. 2011. The effects of corni fructus extract and its fractions against \u03b1-glucosidase inhibitory activities in vitro and sucrose tolerance in normal rats. Am J Chin Med<\/i> 39: 367\u2013380.","DOI":"10.1142\/S0192415X11008889"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Pascart, T, Liot\u00e9, F. 2019. Gout: state of the art after a decade of developments. Rheumatology (Oxford)<\/i> 58: 27\u201344.","DOI":"10.1093\/rheumatology\/key002"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Perez-Ruiz, F, Alonso-Ruiz, A, Calabozo, M, Herrero-Beites, A, Garc\u00eda-Erauskin, G, Ruiz-Lucea, E. 1998. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout. Ann Rheum Dis<\/i> 57: 545\u2013549.","DOI":"10.1136\/ard.57.9.545"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Pisaniello, HL, Lester, S, Gonzalez-Chica, D, Stocks, N, Longo, M, Sharplin, GR, Dal Grande, E, Gill, TK, Whittle, SL, Hill, CL. 2018. Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study. Arthritis Res Ther<\/i> 20: 143.","DOI":"10.1186\/s13075-018-1633-9"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Ragab, G, Elshahaly, M, Bardin, T. 2017. Gout: an old disease in new perspective-a review. J Adv Res<\/i> 8: 495\u2013511.","DOI":"10.1016\/j.jare.2017.04.008"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. So, A, Thorens, B. 2010. Uric acid transport and disease. J Clin Invest<\/i> 120: 1791\u20131799.","DOI":"10.1172\/JCI42344"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. So, AK, Martinon, F. 2017. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol<\/i> 13: 639\u2013647.","DOI":"10.1038\/nrrheum.2017.155"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Stamp, LK, Chapman, PT, Palmer, SC. 2016. Allopurinol and kidney function: an update. Joint Bone Spine<\/i> 83: 19\u201324.","DOI":"10.1016\/j.jbspin.2015.03.013"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Sung, YH, Chang, HK, Kim, SE, Kim, YM, Seo, JH, Shin, MC, Shin, MS, Yi, JW, Shin, DH, Kim, H, Kim, CJ. 2009. Anti-inflammatory and analgesic effects of the aqueous extract of corni fructus in murine RAW 264.7 macrophage cells. J Med Food<\/i> 12: 788\u2013795.","DOI":"10.1089\/jmf.2008.1011"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Tang, DH, Ye, YS, Wang, CY, Li, ZL, Zheng, H, Ma, KL. 2017. Potassium oxonate induces acute hyperuricemia in the tree shrew (tupaia belangeri chinensis). Exp Anim<\/i> 66: 209\u2013216.","DOI":"10.1538\/expanim.16-0096"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Tausche, AK, Jansen, TL, Schr\u00f6der, HE, Bornstein, SR, Aringer, M, M\u00fcller-Ladner, U. 2009. Gout-current diagnosis and treatment. Dtsch Arztebl Int<\/i> 106: 549\u2013555.","DOI":"10.3238\/arztebl.2009.0549"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Vargas, F, Romec\u00edn, P, Garc\u00eda-Guill\u00e9n, AI, Wangesteen, R, Vargas-Tendero, P, Paredes, MD, Atucha, NM, Garc\u00eda-Esta\u00f1, J. 2018. Flavonoids in kidney health and disease. Front Physiol<\/i> 9: 394.","DOI":"10.3389\/fphys.2018.00394"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Wan, L, Jiang, JG. 2018. Protective effects of plant-derived flavonoids on hepatic injury. J Funct Foods<\/i> 44: 283\u2013291.","DOI":"10.1016\/j.jff.2018.03.015"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Wertheimer, A, Morlock, R, Becker, MA. 2013. A revised estimate of the burden of illness of gout. Curr Ther Res Clin Exp<\/i> 75: 1\u20134.","DOI":"10.1016\/j.curtheres.2013.04.003"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. White, WB, Saag, KG, Becker, MA, Borer, JS, Gorelick, PB, Whelton, A, Hunt, B, Castillo, M, Gunawardhana, L. CARES Investigators 2018. Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med<\/i> 378: 1200\u20131210.","DOI":"10.1056\/NEJMoa1710895"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Wolkowitz, OM, Lupien, SJ, Bigler, ED. 2007. The \u201csteroid dementia syndrome\u201d: a possible model of human glucocorticoid neurotoxicity. Neurocase<\/i> 13: 189\u2013200.","DOI":"10.1080\/13554790701475468"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Wu, YHS, Chiu, CH, Yang, DJ, Lin, YL, Tseng, JK, Chen, YC. 2013. Inhibitory effects of litchi (Litchi chinensis Sonn.) flower-water extracts on lipase activity and diet-induced obesity. J Funct Foods<\/i> 5: 923\u2013929.","DOI":"10.1016\/j.jff.2013.02.002"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Yi, LT, Li, J, Su, DX, Dong, JF, Li, CF. 2012. Hypouricemic effect of the methanol extract from Prunus mume fruit in mice. Pharm Biol<\/i> 50: 1423\u20131427.","DOI":"10.3109\/13880209.2012.683115"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Yokozawa, T, Yamabe, N, Kim, HY, Kang, KS, Hur, JM, Park, CH, Tanaka, T. 2008. Protective effects of morroniside isolated from Corni Fructus against renal damage in streptozotocin-induced diabetic rats. Biol Pharm Bull<\/i> 31: 1422\u20131428.","DOI":"10.1248\/bpb.31.1422"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Zhang, M, Solomon, DH, Desai, RJ, Kang, EH, Liu, J, Neogi, T, Kim, SC. 2018. Assessment of cardiovascular risk in older patients with gout initiating febuxostat versus allopurinol: population-based cohort study. Circulation<\/i> 138: 1116\u20131126.","DOI":"10.1161\/CIRCULATIONAHA.118.033992"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Zhang, Y, Neogi, T, Chen, C, Chaisson, C, Hunter, DJ, Choi, HK. 2012. Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum<\/i> 64: 4004\u20134011.","DOI":"10.1002\/art.34677"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/84\/8\/84_21-0671\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T03:17:06Z","timestamp":1660965426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/84\/8\/84_21-0671\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.21-0671","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"21-0671"}}